Compared to the control cell line,eFGF1-161Tb showed much higher uptake and significantlyenhanced cytotoxicity on both FGFR1 and FGFR4 overexpressing celllines, which suggests that eFGF1-161Tb is a promising candidatefor targeted cancer therapy. This evidence concerns the gene FGFR1 and cancer.